BofA cuts CRISPR Therapeutics stock price target to $83 on valuation
ORIGINAL SOURCE →via Investing.com
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] EU plans €6M program to support Palestinian victims of extremist settler violence
- [FINANCE] Coinbase cuts 14% of staff as AI reshapes how crypto companies operate
- [FINANCE] Looming Quantum Threat as PQC Market Expands
- [FINANCE] Can central banks curb inflation as energy costs rise? - Al Jazeera
- [FINANCE] Cytokinetics succeeds where Bristol Myers failed in heart muscle disease
- [FINANCE] The Most Important SpaceX IPO Filing Is (Likely) About 2 Weeks Away - Yahoo Finance